The Type III Effectors NleE and NleB from Enteropathogenic and OspZ from Block Nuclear Translocation of NF-κB p65

English version České info

Many bacterial pathogens utilize a type III secretion system to deliver multiple effector proteins into host cells. Here we found that the type III effectors, NleE from enteropathogenic E. coli (EPEC) and OspZ from Shigella, blocked translocation of the p65 subunit of the transcription factor, NF-κB, to the host cell nucleus. NF-κB inhibition by NleE was associated with decreased IL-8 expression in EPEC-infected intestinal epithelial cells. Ectopically expressed NleE also blocked nuclear translocation of p65 and c-Rel, but not p50 or STAT1/2. NleE homologues from other attaching and effacing pathogens as well OspZ from Shigella flexneri 6 and Shigella boydii, also inhibited NF-κB activation and p65 nuclear import; however, a truncated form of OspZ from S. flexneri 2a that carries a 36 amino acid deletion at the C-terminus had no inhibitory activity. We determined that the C-termini of NleE and full length OspZ were functionally interchangeable and identified a six amino acid motif, IDSY(M/I)K, that was important for both NleE- and OspZ-mediated inhibition of NF-κB activity. We also established that NleB, encoded directly upstream from NleE, suppressed NF-κB activation. Whereas NleE inhibited both TNFα and IL-1β stimulated p65 nuclear translocation and IκB degradation, NleB inhibited the TNFα pathway only. Neither NleE nor NleB inhibited AP-1 activation, suggesting that the modulatory activity of the effectors was specific for NF-κB signaling. Overall our data show that EPEC and Shigella have evolved similar T3SS-dependent means to manipulate host inflammatory pathways by interfering with the activation of selected host transcriptional regulators.

Vyšlo v časopise: The Type III Effectors NleE and NleB from Enteropathogenic and OspZ from Block Nuclear Translocation of NF-κB p65. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000898
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000898

Souhrn

Zdroje

1. CoburnB

SekirovI

FinlayBB

2007 Type III secretion systems and disease. Clin Microbiol Rev 20 535 549

2. FrankelG

PhillipsAD

2008 Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol 10 549 556

3. ArbibeL

KimDW

BatscheE

PedronT

MateescuB

2007 An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8 47 56

4. LiH

XuH

ZhouY

ZhangJ

LongC

2007 The phosphothreonine lyase activity of a bacterial type III effector family. Science 315 1000 1003

5. KramerRW

SlagowskiNL

EzeNA

GiddingsKS

MorrisonMF

2007 Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog 3 e21

6. LiQ

VermaIM

2002 NF-kappaB regulation in the immune system. Nat Rev Immunol 2 725 734

7. PerkinsND

2007 Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8 49 62

8. TobeT

BeatsonSA

TaniguchiH

AbeH

BaileyCM

2006 An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 103 14941 14946

9. WickhamME

LuppC

VazquezA

MascarenhasM

CoburnB

2007 Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect 9 400 407

10. ZurawskiDV

MumyKL

BadeaL

PrenticeJA

HartlandEL

2008 The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect Immun 76 369 379

11. NobeR

NougayredeJP

TaiebF

BardiauM

CassartD

2009 Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-{kappa}B-dependent innate responses in a manner independent of a type III secreted OspG orthologue. Microbiology

12. Ruchaud-SparaganoMH

MarescaM

KennyB

2007 Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol 9 1909 1921

13. SharmaR

TesfayS

TomsonFL

KantetiRP

ViswanathanVK

2006 Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 290 G685 694

14. Al-SadiRM

MaTY

2007 IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 178 4641 4649

15. KingP

GoodbournS

1994 The beta-interferon promoter responds to priming through multiple independent regulatory elements. J Biol Chem 269 30609 30615

16. ColeC

BarberJD

BartonGJ

2008 The Jpred 3 secondary structure prediction server. Nucleic Acids Res 36 W197 201

17. GaoX

WanF

MateoK

CallegariE

WangD

2009 Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog 5 e1000708

18. KellyM

HartE

MundyR

MarchesO

WilesS

2006 Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun 74 2328 2337

19. IguchiA

ThomsonNR

OguraY

SaundersD

OokaT

2009 Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191 347 354

20. DaiR

PhillipsRA

AhmedSA

2007 Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. J Immunol 179 1776 1783

21. SavkovicSD

KoutsourisA

HechtG

1997 Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol 273 C1160 1167

22. KhanMA

BouzariS

MaC

RosenbergerCM

BergstromKS

2008 Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli (EPEC) and Citrobacter rodentium. Infect Immun 76 1410 2

23. HaufN

ChakrabortyT

2003 Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol 170 2074 2082

24. VallabhapurapuS

KarinM

2009 Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27 693 733

25. NadlerC

BaruchK

KobiS

MillsE

HavivG

2010 The Type III Secretion Effector NleE Inhibits NF-kappaB Activation. PLoS Pathog 6 e1000743

26. KimDW

LenzenG

PageAL

LegrainP

SansonettiPJ

2005 The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 102 14046 14051

27. LevineMM

BergquistEJ

NalinDR

WatermanDH

HornickRB

1978 Escherichia coli strains that cause diarrhoea but do not produce heat- labile or heat-stable enterotoxins and are non-invasive. Lancet 1 1119 1122

28. PernaNT

PlunkettG3rd

BurlandV

MauB

GlasnerJD

2001 Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409 529 533

29. MundyR

PickardD

WilsonRK

SimmonsCP

DouganG

2003 Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol Microbiol 48 795 809